Anmu Xie

2.9k total citations
99 papers, 2.1k citations indexed

About

Anmu Xie is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anmu Xie has authored 99 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Neurology, 26 papers in Molecular Biology and 25 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anmu Xie's work include Parkinson's Disease Mechanisms and Treatments (52 papers), Neurological disorders and treatments (17 papers) and Nuclear Receptors and Signaling (16 papers). Anmu Xie is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (52 papers), Neurological disorders and treatments (17 papers) and Nuclear Receptors and Signaling (16 papers). Anmu Xie collaborates with scholars based in China and United States. Anmu Xie's co-authors include Xiaona Zhang, Liying Yang, Lijun Liu, Hongyan Wang, Jing Gao, Dong-Mei Meng, Lin Xu, Jin‐Tai Yu, Lan Tan and Jing Wang and has published in prestigious journals such as Brain Research, Neuroscience and IEEE Transactions on Medical Imaging.

In The Last Decade

Anmu Xie

93 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anmu Xie China 25 743 723 407 397 350 99 2.1k
Iddo Magen Israel 24 840 1.1× 598 0.8× 402 1.0× 617 1.6× 215 0.6× 38 2.0k
Jianfang Ma China 24 615 0.8× 839 1.2× 650 1.6× 256 0.6× 261 0.7× 64 1.9k
Chandramohan Wakade United States 27 423 0.6× 738 1.0× 340 0.8× 501 1.3× 389 1.1× 43 2.2k
Wenjie Xie China 23 822 1.1× 687 1.0× 329 0.8× 723 1.8× 399 1.1× 55 2.1k
Anamitra Ghosh United States 21 811 1.1× 1.1k 1.5× 492 1.2× 673 1.7× 539 1.5× 33 2.4k
Vı́ctor Tapias United States 23 862 1.2× 693 1.0× 458 1.1× 650 1.6× 305 0.9× 34 2.2k
Yuyan Tan China 23 765 1.0× 600 0.8× 391 1.0× 369 0.9× 496 1.4× 69 2.1k
Asako Yoritaka Japan 20 1.2k 1.6× 690 1.0× 436 1.1× 584 1.5× 311 0.9× 48 2.2k
Lucia Petrozzi Italy 28 475 0.6× 875 1.2× 543 1.3× 360 0.9× 253 0.7× 55 2.0k
Victoria Trembovler Israel 31 796 1.1× 972 1.3× 461 1.1× 599 1.5× 338 1.0× 61 2.9k

Countries citing papers authored by Anmu Xie

Since Specialization
Citations

This map shows the geographic impact of Anmu Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anmu Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anmu Xie more than expected).

Fields of papers citing papers by Anmu Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anmu Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anmu Xie. The network helps show where Anmu Xie may publish in the future.

Co-authorship network of co-authors of Anmu Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Anmu Xie. A scholar is included among the top collaborators of Anmu Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anmu Xie. Anmu Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Anmu, et al.. (2025). Chlorogenic acid mitigates glucocorticoid-induced osteoporosis via modulation of HER2/AKT/mTOR signaling pathway. Journal of Integrative Medicine. 23(6). 670–682.
2.
Zhou, Yuting, Yaqing Li, Zhen Kong, et al.. (2025). Uncovering the Associations of LILRB4 Genotypes With Parkinson's Disease: From Clinical Traits to Potential Pathologies. CNS Neuroscience & Therapeutics. 31(7). e70522–e70522.
4.
Liu, Yumei, et al.. (2024). TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition. Molecular Neurobiology. 62(2). 1813–1825. 3 indexed citations
5.
Liu, Yumei, et al.. (2024). Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease. Clinical and Translational Science. 17(12). e70111–e70111. 1 indexed citations
6.
Li, Chengqian, et al.. (2024). Combined diagnosis for Parkinson's disease via gait and eye movement disorders. Parkinsonism & Related Disorders. 123. 106979–106979. 7 indexed citations
7.
Sun, Xiaohui, et al.. (2024). Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study. Clinical and Translational Science. 17(1). e13720–e13720. 3 indexed citations
9.
Zhang, Xue, Ling Wang, Haiyan Li, et al.. (2023). Effects of soluble TREM2 on motor progression in Parkinson’s disease. Neuroscience Letters. 807. 137277–137277. 5 indexed citations
10.
Ding, Li, et al.. (2023). Mechanisms of the Ping-wei-san plus herbal decoction against Parkinson’s disease: Multiomics analyses. Frontiers in Nutrition. 9. 945356–945356. 7 indexed citations
11.
Sun, Xiaohui, et al.. (2023). CD33 polymorphisms and Parkinson’s disease Parkinson’s disease in northern Chinese Han population: A case-control study. Neuroscience Letters. 812. 137400–137400. 3 indexed citations
12.
Sun, Xiaohui, et al.. (2023). Association of AQP4 single nucleotide polymorphisms (rs335929 and rs2075575) with Parkinson’s disease: A case-control study. Neuroscience Letters. 797. 137062–137062. 10 indexed citations
13.
Li, Yuanyuan, Aonan Zhao, Mengyue Niu, et al.. (2022). Parkinson's disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study. Journal of Neuroinflammation. 19(1). 116–116. 22 indexed citations
14.
Han, Bin, et al.. (2022). Upregulation of PGC-1α Attenuates Oxygen-Glucose Deprivation-Induced Hippocampal Neuronal Injury. Neural Plasticity. 2022. 1–10. 8 indexed citations
16.
Zhang, Xue, et al.. (2020). Association of IL-16 gene polymorphisms with sporadic Parkinson’s disease in a Han Chinese population. Neuroscience Letters. 724. 134877–134877. 6 indexed citations
17.
Yang, Liying, et al.. (2020). Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway. Life Sciences. 259. 118159–118159. 23 indexed citations
18.
Zhang, Xue & Anmu Xie. (2019). Improvement of Subthalamic Nucleus Deep Brain Stimulation in Sleeping Symptoms in Parkinson’s Disease: A Meta-Analysis. Parkinson s Disease. 2019. 1–9. 6 indexed citations
19.
Zhang, Xiaona, et al.. (2018). Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus in Parkinson’s Disease: A Meta-Analysis. Parkinson s Disease. 2018. 1–7. 21 indexed citations
20.
He, Qing, Tingting Du, Anmu Xie, et al.. (2011). DMT1 polymorphism and risk of Parkinson’s disease. Neuroscience Letters. 501(3). 128–131. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026